Market Snapshot

BSE Sensex: 73319.55 0.25%
BSE 500: 32839.65 0.08%
BSE 200: 10347.1 0.11%
BSE 100: 23846.26 0.16%
BSE BANKEX: 58009.41 0.22%
BSE IT: 29288.17 2.42%
Nifty 50: 22713.1 0.15%
Nifty 500: 20938.35 0.02%
Nifty 200: 12728 0.06%
Nifty 100: 23304.2 0.14%
Nifty Midcap 100: 53677.05 -0.26%
Nifty Small 100: 15650.5 -0.38%
Nifty IT: 30441.45 2.60%
Nifty PSU Bank: 8134.4 -0.37%

News:

Vikran Engineering bags LoAs w...
Bajaj Housing Finance clocks 2...
Dabur India expects domestic b...
Kernex Microsystems bags Rs 91...
J&K Bank?s gross advances grow...

Ambalal Sarabhai Enterprises Ltd Share Price – BSE
Pharmaceuticals, Small Cap

Invest

02 Apr 2026 | 03:59 PM

26.20

-0.27 (-1.02%)

Add to Watchlist

This awesome feature is still in our labs.
Set Alert

This awesome feature is still in our labs.

Underperforms Index

-29.78%

Return (1Y)

Underperformed BSE Sensex by 25.47%
More Volatile

2.84%

Standard Deviation (1Y)

Higher than BSE Sensex by 1.99%
Not so consistent

4/12

Months

underperformed BSE Sensex
AxisDirect View

No View

52 Week High-Low

News & Announcements

Ambalal Sarabhai Enterprises consolidated net profit rises 63.23% in the December 2025 quarter
50 days ago

Ambalal Sarabhai Enterprises consolidated net profit rises 63.23% in the December 2025 quarter

13 - Feb - 2026 12:00 | 50 days ago

Net profit of Ambalal Sarabhai Enterprises rose 63.23% to Rs 3.64 crore in the quarter ended December 2025 as against Rs 2.23 crore during the previous quarter ended December 2024. Sales rose 13.12% to Rs 52.00 crore in the quarter ended December 2025 as against Rs 45.97 crore during the previous quarter ended December 2024.

Particulars Quarter Ended
Dec. 2025 Dec. 2024 % Var.

Sales 52.00 45.97 13

OPM % 7.85 -1.52 -

PBDT 6.14 3.92 57

PBT 5.18 2.93 77

NP 3.64 2.23 63

Powered by Capital Market - Live News
Ambalal Sarabhai Enterprises to discuss results
58 days ago

Ambalal Sarabhai Enterprises to discuss results

05 - Feb - 2026 12:00 | 58 days ago

Ambalal Sarabhai Enterprises will hold a meeting of the Board of Directors of the Company on 12 February 2026.
Powered by Capital Market - Live News
Ambalal Sarabhai Enterprises reports consolidated net loss of Rs 0.56 crore in the September 2025 quarter
142 days ago

Ambalal Sarabhai Enterprises reports consolidated net loss of Rs 0.56 crore in the September 2025 quarter

13 - Nov - 2025 12:00 | 142 days ago

Net loss of Ambalal Sarabhai Enterprises reported to Rs 0.56 crore in the quarter ended September 2025 as against net profit of Rs 2.62 crore during the previous quarter ended September 2024. Sales declined 0.56% to Rs 44.45 crore in the quarter ended September 2025 as against Rs 44.70 crore during the previous quarter ended September 2024.

Particulars Quarter Ended
Sep. 2025 Sep. 2024 % Var.

Sales 44.45 44.70 -1

OPM % 0.81 5.68 -

PBDT 1.02 4.12 -75

PBT -0.04 3.11 PL

NP -0.56 2.62 PL

Powered by Capital Market - Live News
Ambalal Sarabhai Enterprises to conduct board meeting
150 days ago

Ambalal Sarabhai Enterprises to conduct board meeting

05 - Nov - 2025 12:00 | 150 days ago

Ambalal Sarabhai Enterprises will hold a meeting of the Board of Directors of the Company on 12 November 2025.
Powered by Capital Market - Live News

Price vs Volume

Stock Trivia

Ambalal Sarabhai Enterprises Ltd has opened at 25.51 i.e -3.63% below then yesterday's closing price of 26.47

Peer Comparison on Risk - Return

Thanks for Liking, Please spread your love by sharing...

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	52.00	45.97	13
OPM %	7.85	-1.52	-
PBDT	6.14	3.92	57
PBT	5.18	2.93	77
NP	3.64	2.23	63

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	44.45	44.70	-1
OPM %	0.81	5.68	-
PBDT	1.02	4.12	-75
PBT	-0.04	3.11	PL
NP	-0.56	2.62	PL

General Notifications

My Notifications

Research Notifications

Ambalal Sarabhai Enterprises Ltd Share Price – BSE Pharmaceuticals, Small Cap

26.20 -0.27 (-1.02%)

News & Announcements

Price vs Volume

Stock Trivia

Ambalal Sarabhai Enterprises Ltd Share Price – BSE
Pharmaceuticals, Small Cap

26.20

-0.27 (-1.02%)